Systemic chemotherapy for cancer: from weapon to treatment

The Lancet Oncology

Volumn 9, Issue 3, 2008, Pages 304-

  Joensuu, Heikki ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DOXORUBICIN; MUSTARD GAS DERIVATIVE; PREDNISONE; PROCARBAZINE; TRICHLORMETHINE; VINBLASTINE; VINCRISTINE; ALKYLATING AGENT; CHEMICAL WARFARE AGENT;

BLINDNESS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMICAL WARFARE; DEATH; DRUG TOLERABILITY; HODGKIN DISEASE; HUMAN; LARYNX EDEMA; LUNG EDEMA; LUNG INJURY; NOTE; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; SKIN EDEMA; SKIN ULCER; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; ARTICLE; FEMALE; HISTORY;

ANTINEOPLASTIC AGENTS, ALKYLATING; CHEMICAL WARFARE AGENTS; FEMALE; HISTORY, 20TH CENTURY; HODGKIN DISEASE; HUMANS; MECHLORETHAMINE;

EID: 40749142413     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(08)70075-5     Document Type: Note

References (5)

1. Goodman L., Wintrobe M., Dameshek W., Goodman M., Gilman A., and McLennan M. Nitrogen mustard therapy. JAMA 132 (1946) 126-132
2. Adair F., and Bagg H. Experimental and clinical studies on the treatment of cancer by dichlororethylsulphide (mustard gas). Ann Surg 93 (1931) 190-199
3. MacGregor A. The search for a chemical cure for cancer. Med Hist 10 (1966) 374-385
4. DeVita Jr. V., Serpick A., and Carbone P. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73 (1970) 881-895
5. Fermé C., Eghbali H., Meerwaldt J., et al. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease. N Engl J Med 357 (2007) 1916-1927